Option Pharmaceuticals, LLC

Development Status

Both Repedivir and Replenivir are in the testing stage of development.

A USDA-regulated clinical trial is being planned to test the efficacy of Repedivir in a large number of client-owned dogs with naturally-occurring osteoarthritis.  The trial will be randomized, double-blinded and placebo controlled.

The same type of trial will be launched to test Replenivir after the completion of the Repedivir trial.

At this time, neither Repedivir or Replenivir are available to the public.
Please feel free to contact us for any additional information: